SK Chemicals eying sales of 20 billion won with new drug

Published: 2012-08-09 06:56:00

Updated: 2012-08-09 06:56:00

SK Chemicals on Tuesday launched Promac (polaprezinc), a new drug for the treatment of acute and chronic gastritis, in a bid to raise 20 billion won in domestic sales in the first year of launching, the company said.

Developed by Zeria Pharmaceutical Co. in Japan, polaprezinc is a zinc-L-carno...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK